Brain tumors, sequencing, computational biology
We are a computational cancer biology lab with a research focus on the analysis of cancer genomics data to improve our understanding of cancer biology. We have a specialized research interest in understanding disease progression of brain tumors, particularly glioblastoma and glioma. We mostly use high throughput sequencing and computational analysis in our research.
Verhaak Lab WebsiteRoel Verhaak is leading an international group of clinicians and researchers, investigating why gliomas develop resistance and recur after...
Roel Verhaak has joined the global Cancer Grand Challenges team, receiving $25M to take on the challenge of extrachromosomal...
The new technique of methylome profiling, now available from The Jackson Laboratory, provides more precise tumor classification for cancers...
We take a look at the history of genomic sequencing, where it's going in the future, and the power it has to potentially treat diseases...
I am investigating splicing-derived neo-antigens in breast and lung cancer using long-read RNA-sequencing in collaboration with the Palucka...
A research team at JAX is boosting the speed and accuracy of tumor sample image analysis, for multiple cancer types,...
Using sophisticated labeling methods, a team led by Professor Karolina Palucka, M.D., Ph.D., and Jan Martinek, Ph.D.,...
The major focus of my research program is to investigate the epigenetic reprogramming along the continuum of cancer initiation to disease...
Join us as we discuss a new onco-hu model of ER+, ESR1-mutant, endocrine-resistant metastatic breast cancer.
I have joined Verhaak lab to study the role of ecDNA in cancer
Analysis and pipeline development of spatial proteomics and trascriptomics data employing machine learning techniques.
Working in the comparative genomics field to study spontaneous development of canine and human glioma with emphasis on characterizing...
Professor Roel Verhaak, Ph.D., is focused on the analysis of cancer genomics data to improve our understanding of cancer...
Brain tumors, sequencing, computational biology.
Join our live discussion on preclinical efficacy and safety testing for novel antibody-based therapeutics.